Exploring how saliva's sugar components help fight oral infections
A Human Salivary Glycome Discovery Platform for Interrogating Glycan Function in Oral Innate Immunity
This study is looking at how certain sugars in your saliva help protect your mouth from germs, and it could lead to new ways to treat oral infections, so you can have better oral health.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Natglycan, LLC NIH-funded |
| Lab location | 1 site (Tucker, UNITED STATES) |
| Project ID | NIH-10484608 on NIH RePORTER |
What this research studies
This research investigates the role of glycan components in saliva, which are crucial for the body's first line of defense against harmful pathogens in the mouth. By creating a glycan microarray, the study aims to identify how these sugar molecules interact with proteins that bind to them, influencing the immune response. Patients may benefit from understanding how these interactions can affect oral health and potentially lead to new treatments for oral infections. The research will involve analyzing saliva samples to uncover the specific glycans present and their functions in immunity.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with oral health issues or those interested in understanding the biological mechanisms of oral immunity.
Not a fit: Patients without any oral health concerns or those not producing saliva may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating oral infections by enhancing our understanding of saliva's protective functions.
How similar studies have performed: Previous research has shown promise in understanding glycan interactions in other biological contexts, suggesting potential for success in this novel approach.
Where this research is happening
Tucker, UNITED STATES
- Natglycan, LLC — Tucker, United States (Active)
Researchers
- Principal investigator: Smith, David Fletcher — Natglycan, LLC
- Study coordinator: Smith, David Fletcher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.